Low HDL‐cholesterol: common and under‐treated, but which drug to use?

A. Wierzbicki
DOI: https://doi.org/10.1111/j.1742-1241.2006.01122.x
IF: 2.6
2006-10-01
International Journal of Clinical Practice
Abstract:paper that patients should be offered medical intervention first. Now that I have laid out this rather dismal picture, what is the answer? How about focusing on education of the PCP? Let us focus on the prostate for what it is; an underappreciated gland that should not be so misunderstood. If the PCP becomes comfortable, then they can relay that to the patients and it is a win-win. And maybe, more uniform and earlier intervention will lead to less complications of EP, such as acute urinary retention and decreased quality of life. My friends have heard this education issue from me several times over the last few years. Urological health starts in the office of the PCP, and only when it is refractory should it go the urologist. This is not only for EP, but also for overactive bladder, hypogonadism, interstitial cystitis and erectile dysfunction. I hate to get on the soapbox, but these diseases are not surgical in the early phases. Maybe, exposure to urological health can become a more integral part of the core curriculum for the PCP. Or perhaps, there should be more emphasis on postgraduate or after residency training. We can set up a UroSchool that has, as its mission, the intent on basic urological training for the PCP. We can call it P.U. (now, I meant that one). My musical friend at Harvard is now a very successful paediatric urologist, but maybe we can get him to coach the cheer squad. M. T. Rosenberg Mid Michigan Health Centers, Jackson, MI, USA
What problem does this paper attempt to address?